Moleculin Biotech Secures $5.8 Million Through Warrant Exercise #United_States #Houston #Annamycin #Moleculin #MBRX
1
0
0
0
Moleculin Biotech Secures $5.8 Million Through Warrant Exercise #United_States #Houston #Annamycin #Moleculin #MBRX
Moleculin's Groundbreaking Approval Marks Start of Phase 3 AML Clinical Trials in Europe #United_States #Houston #AML #Annamycin #Moleculin